Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 14, 2012
Recipharm and ViroPharma today signed a commercial contract to initiate supply of Plenadren® for named patient use. In addition, ViroPharma are investing in capital equipment at the Recipharm manufacturing site - enabling large scale manufacturing ...
read more
Wednesday, February 17, 2021
Recipharm, has extended its manufacturing license to include immunology products.
read more
Thursday, December 10, 2020
Recipharm has announced an investment and capacity expansion at its facility in Israel.
read more
Wednesday, February 23, 2022
Recipharm is investing to expand its sterile fill and finish production capabilities at its site in Monts, France. The manufacturing facility which specializes in the aseptic filling of pharmaceutical products, including biologics into vials and ...
read more
27th April 2012 - Recipharm Ltd in Ashton under Lyne, UK is pleased to launch a dedicated recovery service for reworking pharmaceutical products under cGMP conditions at its UK site.
read more
Tuesday, December 17, 2019
Recipharm, the CDMO, has partnered with biotechnology company Aptahem, for the formulation of Apta-1 drug candidate.
read more
Wednesday, January 28, 2015
Recipharm, the leading contract development and manufacturing organisation (CDMO), is pleased to announce its readiness for serialisation and the successful completion of a complex serialisation project for China on behalf of one of its customers. A ...
read more
The company earmarks new EUR 90 million loan facility for further acquisition of niche CDMOs, investment in existing facilities and building long term partnerships with major pharmaceuticals companies.
read more
Wednesday, September 20, 2017
Recipharm has entered into collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose products.
read more
Wednesday, January 20, 2021
Recipharm and Enzymatica have signed a broadened contract for the manufacture of ColdZyme.
read more
Friday, December 20, 2013
RPH Pharmaceuticals AB, a subsidiary of Recipharm AB, announces the filing of an application for an infectious disease drug product in a range of European countries. The product has been developed through a partnership with Swedish pharmaceutical ...
read more
Thursday, November 09, 2017
Recipharm will initiate a process with the intention of discontinuing manufacturing operations at its facilities in Stockholm and Höganäs, Sweden.
read more
Thursday, December 20, 2018
Recipharm announced that it will explore the discontinuance of operations at its solid dose manufacturing facility in Ashton-under-Lyne, UK.
read more
Wednesday, November 13, 2019
Recipharm and CTC Clinical Trial Consultants have expanded their partnership with the divestment of Recipharm’s GLP bioanalysis business to the Center for Translational Research group.
read more
Thursday, September 14, 2017
Recipharm and Kancera have signed a contract for the development and manufacture of the pharmaceutical candidate KAND567.
read more